Evidence map›Paper›PMID 25288669›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2015

DNA double-strand breaks by Cr(VI) are targeted to euchromatin and cause ATR-dependent phosphorylation of histone H2AX and its ubiquitination.

Zachary DeLoughery, Michal W Luczak, Sara Ortega-Atienza, Anatoly Zhitkovich

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Chromium as a Risk Factor for Breast Cancer: A Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2022
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Chemical mechanisms of DNA damage by carcinogenic chromium(VI).Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Nuclear and Cytoplasmic Functions of Vitamin C.Chemical research in toxicology · 2020
    Review
  18. Chromium Pollution in European Water, Sources, Health Risk, and Remediation Strategies: An Overview.International journal of environmental research and public health · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zachary DeLougheryDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912.
Michal W LuczakDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912.
Sara Ortega-AtienzaDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912.
Anatoly ZhitkovichDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912 anatoly_zhitkovich@brown.edu.
Brown University · US

Funding

GENOTOXICITY OF CHROMIUM COMPOUNDSR01ES008786 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZHITKOVICH, ANATOLY · 1997 to 2019
$5.7M
NIEHS NIH HHS ES008786NIEHS NIH HHS R01 ES008786
6 · The paper itself

Abstract

Hexavalent chromium is a human respiratory carcinogen that undergoes intracellular activation in vivo primarily via reduction with ascorbate. Replication of Cr-adducted DNA triggers mismatch repair that generates toxic DNA double-strand breaks (DSBs) as secondary lesions. Here, we examined the intranuclear distribution of chromate-induced breaks and a central DSB signaling branch targeting histone H2AX. Using ascorbate-restored cells (H460 human lung epithelial cells, normal human lung and normal mouse embryonic fibroblasts (MEFs)), we found that Cr(VI) produced a typical DSB-associated spectrum of H2AX modifications, including its Ser139-phosphorylated (known as γH2AX) and mono- and diubiquitinated forms. However, whereas canonical DSB signaling relies on ATM, the formation of γH2AX and its ubiquitinated products by Cr(VI) was dependent on ATR kinase. Based on the established mode of ATR activation, this suggests that Cr-induced DSB are not blunt-ended and likely contain single-stranded tails. Confocal imaging with markers of active and inactive chromatin revealed a selective formation of Cr-induced DSB in euchromatin of mouse and human cells. In contrast to DSB, Cr-DNA adducts were produced in both types of chromatin. The euchromatin targeting of Cr-induced DSB makes these lesions particularly dangerous by increasing the probability of deleting active tumor suppressors and producing oncogenic translocations. Accumulation of transcription-inhibiting ubiquitinated forms of γH2AX in euchromatin is expected to contribute to the ability of Cr(VI) to suppress upregulation of inducible genes.

Indexed as

DNA Breaks, Double-StrandedAnimalsAscorbic AcidAtaxia Telangiectasia Mutated ProteinsCell Line, TumorCell NucleusCell SurvivalChromatesChromiumDose-Response Relationship, DrugEuchromatinGene Expression RegulationHistonesHumansMiceMicroscopy, ConfocalAscorbic AcidAtaxia Telangiectasia Mutated ProteinsATR protein, humanAtr protein, mouseChromatesChromiumchromium hexavalent ionEuchromatingamma-H2AX protein, mouseH2AX protein, humanHistonespotassium chromate(VI)Potassium CompoundsATRcancerchromateeuchromatinhexavalent chromiumγ-H2AX

Identifiers

PMID25288669
PMCPMC4274381
OpenAlexW2146537887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.